🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsOral GLP-1 AgonistsHow far away are we really from an oral option — 12 month update Page 8

How far away are we really from an oral option — 12 month update

HPLC_Greg Wed, Jun 4, 2025 at 7:45 PM 47 replies 2,552 viewsPage 8 of 10
mark_tokyo
Member
456
1,890
Jun 2024
Tokyo, JP
Jun 14, 2025 at 8:26 PM#36
BiostatsBrad said:
The boring version of this is the one that works, and the boring version is: measure a baseline, change one variable, wait, measure again under the…

This is where I part company with the consensus forming above. I think the framing smuggles in the conclusion. Ask it the other way round and the obvious answer reverses, which usually means the question is doing the work.

39 12pete_manc_UK, anna.melb_AU, mark_tokyo and 36 others
Reply Quote Save Share Report
SkepticalSean
Member
98
345
Jan 2025
Maine
Jun 15, 2025 at 9:01 AM#37
BiostatsBrad said:
The boring version of this is the one that works, and the boring version is: measure a baseline, change one variable, wait, measure again under the…

Agreed, and one caution: a single measurement is not a measurement. Anything that moves day to day needs a trend before it means anything at all.

40 13paige_pharma, emma_london, tammy_FL and 37 others
Reply Quote Save Share Report
BethLabQueen
Senior Member
1,234
5,678
May 2024
Virginia
Online
Jun 15, 2025 at 9:35 PM#38
BiostatsBrad said:
The boring version of this is the one that works, and the boring version is: measure a baseline, change one variable, wait, measure again under the…

Saving this. It is the first explanation that did not require me to already understand it. Adding it to my notes with a link back to this thread.

41 14lori_vegas, Dr.PulmRoch, maya_sedona and 38 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
rachel_ABQ
Member
178
890
Dec 2024
Albuquerque, NM
Jun 16, 2025 at 10:09 AM#39

Adding the clinical framing, because it changes how the question reads. The honest answer is that the effect is real, the magnitude is contested, and the individual variation is larger than either. Those three things can all be true at once, and most arguments here are two people holding different parts of that.

42 15SkepticalSean, Dr.CardioMD, EndoResFellow and 39 others
Reply Quote Save Share Report
Dr.ReproEndo
Senior Member
1,890
8,901
Jan 2024
Scottsdale, AZ
Jun 16, 2025 at 10:43 PM#40
rachel_ABQ said:
The honest answer is that the effect is real, the magnitude is contested, and the individual variation is larger than either.

Adding a me-too, because a thread of one person's experience is not much use. Posting only so the count is not one.

14 12carl_compliance, DanielChem_CHI, marco_milano and 11 others
Reply Quote Save Share Report

Similar Threads

Orforglipron Phase 3 ATTAIN-1 topline — oral non-peptide GLP-116 replies
Oral semaglutide 50mg (Rybelsus HD) — OASIS program results12 replies
Danuglipron BID dosing — Pfizer oral GLP-1 update7 replies
Oral vs injectable GLP-1: bioavailability and efficacy comparison5 replies
Orforglipron food interaction profile — no fasting requirement15 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register